Verrica Pharmaceuticals: YCANTH Granted NCE Status By FDA
Verrica Pharmaceuticals Inc. (VRCA) announced the company's lead product, YCANTH, has received New Chemical Entity Status and a listing in the Orange Book from the FDA, providing a minimum five years of regulatory exclusivity.